Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment

Aim of our study was to assess the load of bone disease at starting and during Ra-223 treatment as an overall survival (OS) predictor in metastatic castration-resistant prostate cancer (mCRPC) patients. Bone scan index (BSI) is defined as the percentage of total amount of bone metastasis on whole-body scintigraphic images. We present a specific software (DASciS) developed by an engineering team of “Sapienza” University of Rome for BSI calculation..

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:54

Enthalten in:

Radiology and Oncology - 54(2019), 1, Seite 40-47

Sprache:

Englisch

Beteiligte Personen:

Frantellizzi Viviana [VerfasserIn]
Pani Arianna [VerfasserIn]
Ippoliti Maria Dea [VerfasserIn]
Farcomeni Alessio [VerfasserIn]
Aloise Irvin [VerfasserIn]
Colosi Mirco [VerfasserIn]
Polito Claudia [VerfasserIn]
Pani Roberto [VerfasserIn]
Vincentis Giuseppe De [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
doi.org [kostenfrei]
Journal toc [kostenfrei]

Themen:

Bone disease
Bone scan index
Dascis software
Mcrpc
Medical physics. Medical radiology. Nuclear medicine
Overall survival
Radium223 dichloride

doi:

10.2478/raon-2019-0058

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ069386625